The re-emergence of swine dysentery (Brachyspira-associated muco-haemorrhagic colitis) since the late 2000's has illuminated diagnostic challenges associated with this genus. The methods used to detect, identify and characterize Brachyspira from clinical samples have not been standardized and laboratories frequently rely heavily on in-house techniques. Particularly concerning is the lack of standardized methods for determining and interpreting the antimicrobial susceptibility of Brachyspira spp. The integration of laboratory data into a treatment plan is a critical component of prudent antimicrobial usage, the lack of standardized methods is therefore an important limitation to the evidence based use of antimicrobials. This review will focus on describing the methodological limitations and inconsistencies between current susceptibility testing schemes employed for Brachyspira, provide an overview of what we do know about the susceptibility of these organisms and suggest future directions to improve and standardize diagnostic strategies. was not isolated until the early 1970s (Harris et al. 1972; Whiting et al. 1921). Since the late 2000s, several additional distinct taxa ('Brachyspira hampsonii' and 'Brachyspira suanatina') have been found to causally associated with this syndrome (Burrough 2017) . Swine dysentery, which primarily affects grower-finisher pigs, is the most economically damaging disease associated with Brachyspira attributable to both mortality and production limiting sub-optimal feed conversion (Alvarez-Ordonez et al. 2013) . Brachyspira pilosicoli has a broad host spectrum including pigs, other domestic animals, wildlife and humans (Trivett-Moore et al. 1998). In pigs, intestinal spirochetosis caused by Brachyspira pilosicoli typically affects pigs within 7 to 14 days post-weaning (Trott et al. 1996). Porcine intestinal spirochetosis is characterized by diarrhea often described as having a "wet cement" consistency (Hampson and Duhamel 2006). In chickens, Brachyspira intermedia and pilosicoli are associated with diarrhea, decreased production and fecal staining of eggs (Mappley et al. 2014). Finally, human intestinal spirochetosis caused by B. pilosicoli or B. aalborgi, is an infrequent cause of diarrhea most commonly affecting children and immunocompromised individuals (Helbling et al. 2012; Tateishi et al. 2015). America and the emergence of 'Brachyspira hampsonii' in Europe have been described (Mahu et al. 2014; Martinez-Lobo et al. 2013; Rubin et al. 2013a). This re-emergence has included the identification of novel taxa causing a dysentery like disease ('Brachyspira hampsonii' and 'Brachyspira suanatina') which have been effectively but not validly described (Chander et al. 2012; Mirajkar et al. 2016b; Mushtaq et al. 2015; Perez et al. 2016). The specific etiological diagnosis of Brachyspira associated disease is challenging and relies heavily on PCR and culture based assays; it was therefore not surprising that the emergence of 'B. hampsonii' has been associated with substantial diagnostic challenges. The economic and animal welfare implications of Brachyspira associated disease have led to renewed interest in improving the diagnostic methods used for Brachyspira, including antimicrobial susceptibility test methods to facilitate the evidence based use of antimicrobials. The purpose of this review is therefore to summarize the current state of knowledge regarding the susceptibility of Brachyspira to antimicrobials, the intrinsic methodological limitations associated with Brachyspira and to highlight future research avenues to improve the reproducibility and reliability of Brachyspira antimicrobial susceptibility testing.
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Since the late 2000s the re-emergence of Brachyspira associated disease in pigs in North America and the emergence of 'Brachyspira hampsonii' in Europe have been described (Mahu et al. 2014; Martinez-Lobo et al. 2013; Rubin et al. 2013a ). This re-emergence has included the identification of novel taxa causing a dysentery like disease ('Brachyspira hampsonii' and 'Brachyspira suanatina') which have been effectively but not validly described (Chander et al. 2012; Mirajkar et al. 2016b; Mushtaq et al. 2015; Perez et al. 2016) . The specific etiological diagnosis of Brachyspira associated disease is challenging and relies heavily on PCR and culture based assays; it was therefore not surprising that the emergence of 'B. hampsonii' has been associated with substantial diagnostic challenges. The economic and animal welfare implications of Brachyspira associated disease have led to renewed interest in improving the diagnostic methods used for Brachyspira, including antimicrobial susceptibility test methods to facilitate the evidence based use of antimicrobials. The purpose of this review is therefore to summarize the current state of knowledge regarding the susceptibility of Brachyspira to antimicrobials, the intrinsic methodological limitations associated with Brachyspira and to highlight future research avenues to improve the reproducibility and reliability of Brachyspira antimicrobial susceptibility testing.
General information about Brachyspira

Taxonomy
The genus Brachyspira is within the order Brachyspirales, and was recognized as a distinct genus from Treponema in 1983 (Gupta et al. 2013; Hovind-Hougen et al. 1982; Oren and Garrity 2014 (Calderaro et al. 2013; Prohaska et al. 2014; Warneke et al. 2014) . Identification by phylogenetic analysis, particularly of the NADH oxidase (nox) gene has proven useful and provides comparable, objective data which is portable between labs. Sequence analysis at present is considered the gold standard for species level identification (Perez et al. 2016; Rohde et al. 2014) . DNA sequencing has revealed phylogenetic diversity within the genus Brachyspira, including the novel strain 'B. hampsonii', and a large number of other strains which have not yet been characterized but appear to be distinct from recognized species (Patterson et al. 2013; Rubin et al. 2013b ).
Treatment
In pigs Brachyspira associated disease has been effectively treated with the pleuromutilins, macrolides/lincosamides and carbadox while metronidazole has been effectively used in people with intestinal spirochetosis (Hampson 2012; Helbling et al. 2012 (Aarestrup et al. 2008; Lobova et al. 2004; Mirajkar et al. 2016a; Prasek et al. 2014; Rugna et al. 2015) .
3.0 Antimicrobial susceptibility testing 3.1 Importance of susceptibility testing to the prudent use of antimicrobials
Antimicrobial resistance
The term "antimicrobial resistance" is often used imprecisely. 
General information on susceptibility testing methods
Early in the antibiotic era, the development of antimicrobial susceptibility test methods grew from the need to select the most appropriate therapy in the face of emerging resistance and the availability of new, mechanistically distinct compounds. Brachyspira. However, the use of molecular methods requires knowledge of resistance genes or resistance conferring mutations. It must also be recognized that while these methods can identify resistance, they are insufficient to confirm susceptibility due to the potential presence of novel resistance genes or resistance conferring mutations not included in the assay. inhibited by the drug, or because the culture was insufficiently dense?
Specific challenges to susceptibility testing of
Summary of susceptibility test methods which have been used for Brachyspira
The English language literature through 2017 was searched and studies describing antimicrobial susceptibility testing of Brachyspira were reviewed. Both agar and broth dilution techniques were used although there was substantial variability in the methods reported (Table 2) .
Incubation temperatures ranged from 37 -42 °C with incubation times ranging from 2 to 5 days for agar dilution, and 37 -38 °C and 3-5 days for broth dilution respectively. Where reported, highly variable inoculum densities were described:1 X 10 5 -5 X 10 6 CFU/ml for broth dilution and 10 4 -10 6 CFU/spot for agar dilution tests. Finally, where reported atmospheres with varying composition were used. According to the manufacturers all anaerobic systems yield a final O 2 concentration of ≤1%, but yield highly variable CO 2 concentrations (7->15%). A 2016 study has also described the use of doxycycline gradient strips although this method is not widely used 6.0 Challenges in comparing susceptibility data generated using non-standard tests Further confounding susceptibility data portability is the lack of a consensus scheme for determining species level identification (Rasback et al. 2005) . Researchers have used combinations of conventional methods (ex. culture and biochemical tests) and a variety of molecular methods (ex. nox and 16S-rDNA sequencing and nox-RFLP) which are recognized to have varying levels of sensitivity and specificity.
Objective measures of resistance
Genetic associations with decreased susceptibility to a number of drugs have been elucidated in several Brachyspira spp. (Table 3) . Although this study was small, it highlights the possibility of identifying taxa-specific differences in intrinsic resistance which may prove useful to clinicians for therapeutic selection.
Summary and future directions
The lack of standardized antimicrobial susceptibility test methods and interpretive criteria for
Brachyspira is an important limitation to the evidence based use of antimicrobials for treating clinical disease. These diagnostic limitations have been made acutely problematic by the reemergence of Brachyspira associated disease in North America, and the emergence of novel taxa in Europe. Furthermore, the increasing public scrutiny of antimicrobial usage in agriculture provides constant pressure to ensure that prescribing practices are evidence based and prudent.
Unfortunately, for the reasons described here, we do not recommend that diagnostic laboratories routinely report categorical susceptibility test results for Brachyspira spp. Instead, we encourage our colleagues to continue their research describing temporal changes in MIC and archiving Brachyspira culture collections to facilitate the eventual development of agreed upon test methodology and interpretive criteria.
The lack of consensus on how to identify an isolate to the species level is the most immediate obstacle to improving laboratory diagnostics for Brachyspira. A common ontology is critical for researchers and diagnosticians to make simple comparisons of laboratory prevalence, describe the distribution of particular taxa or to compare the drug susceptibility of two organisms. The next most urgent need is an enriched understanding the genetic determinants of resistance. These genes or mutations have the potential to serve as an objective data point against which phenotypic susceptibility can be benchmarked, potentially serving as a pillar of quality control.
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Finally, we call for additional collaboration in the global Brachyspira diagnostic/research communities. Collaboration and consensus building is going to be a critical step in identifying and recommending best practices for Brachyspira. This leadership was exemplified by Rasback et al., 2005 where the results of a multi-centre ring test were described; such investigations will be essential not only for ensuring method portability and objectivity, but also as a feedback mechanism to identify areas for improvement in individual laboratories.
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